Jing Li1, Wenqi Zhang1,2, Weidong Liu1,3, Jarrett Rong1,4, Yuhan Chen5, Weikuan Gu6,7, Wei Zhang6,8. 1. Department of Orthopedic Surgery and BME-Campbell Clinic, University of Tennessee Health Science Center, Memphis, TN, U.S.A. 2. College of Basic Medicine, Hebei Medical University, Shijiazhuang, P.R. China. 3. The First Hospital of Qiqihar City, Heilongjiang, P.R. China. 4. BSA Biology, Health Science Scholars Honors Program, the University of Texas at Austin, Austin, TX, U.S.A. 5. Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, P.R. China. 6. Department of Orthopedic Surgery and BME-Campbell Clinic, University of Tennessee Health Science Center, Memphis, TN, U.S.A. wgu@uthsc.edu zhangwei666cn@foxmail.com. 7. Research Service, Memphis VA Medical Center, Memphis, TN, U.S.A. 8. Department of Pharmacology, School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, P.R. China.
Abstract
BACKGROUND: Vitamin C has been used in combination with several target genes in the treatment of leukemia. Tet methylcytosine dioxygenase (Tet2), B-cell lymphoma 2 (Bcl2), and solute carrier family 23 member 2 (Slc23a2) are the major target genes in the treatment of leukemia and are relevant to vitamin C. MATERIALS AND METHODS: Using whole-genome expression profiles from mouse livers, the expression quantitative trait locus (eQTL), correlation matrix, and gene network graph were constructed with probes from each of these three genes and with their relative genes. The function of key genes was examined by their pathways and reported information. The results indicated that although direct correlations among their expression levels were not strong, alternative connecting pathways were discovered. By comparing the expression levels of one probe with known sequences from each of the three genes, we identified several key genes, induced myeloid leukemia cell differentiation protein (Mcl1), far upstream element-binding protein 1 (Fubp1), and tumor protein D52-like 2 (Tpd52l2), which play important roles in acute lymphocytic leukemia and acute myelocytic leukemia. In conclusion, Alternative pathways and key genes that connect Tet2, Bcl2, and Slc23a2 for their therapeutic applications with vitamin C were identified. Copyright
BACKGROUND:Vitamin C has been used in combination with several target genes in the treatment of leukemia. Tet methylcytosine dioxygenase (Tet2), B-cell lymphoma 2 (Bcl2), and solute carrier family 23 member 2 (Slc23a2) are the major target genes in the treatment of leukemia and are relevant to vitamin C. MATERIALS AND METHODS: Using whole-genome expression profiles from mouse livers, the expression quantitative trait locus (eQTL), correlation matrix, and gene network graph were constructed with probes from each of these three genes and with their relative genes. The function of key genes was examined by their pathways and reported information. The results indicated that although direct correlations among their expression levels were not strong, alternative connecting pathways were discovered. By comparing the expression levels of one probe with known sequences from each of the three genes, we identified several key genes, induced myeloid leukemia cell differentiation protein (Mcl1), far upstream element-binding protein 1 (Fubp1), and tumor protein D52-like 2 (Tpd52l2), which play important roles in acute lymphocytic leukemia and acute myelocytic leukemia. In conclusion, Alternative pathways and key genes that connect Tet2, Bcl2, and Slc23a2 for their therapeutic applications with vitamin C were identified. Copyright
Authors: Y V Subrahmanyam; S Yamaga; Y Prashar; H H Lee; N P Hoe; Y Kluger; M Gerstein; J D Goguen; P E Newburger; S M Weissman Journal: Blood Date: 2001-04-15 Impact factor: 22.113
Authors: Uta Rabenhorst; Frederic B Thalheimer; Katharina Gerlach; Marek Kijonka; Stefanie Böhm; Daniela S Krause; Franz Vauti; Hans-Henning Arnold; Timm Schroeder; Frank Schnütgen; Harald von Melchner; Michael A Rieger; Martin Zörnig Journal: Cell Rep Date: 2015-06-18 Impact factor: 9.423
Authors: Dhruv Chauhan; Eva Bartok; Moritz M Gaidt; Florian J Bock; Jennifer Herrmann; Jens M Seeger; Petr Broz; Roland Beckmann; Hamid Kashkar; Stephen W G Tait; Rolf Müller; Veit Hornung Journal: Cell Rep Date: 2018-11-27 Impact factor: 9.423
Authors: Mary E Ross; Xiaodong Zhou; Guangchun Song; Sheila A Shurtleff; Kevin Girtman; W Kent Williams; Hsi-Che Liu; Rami Mahfouz; Susana C Raimondi; Noel Lenny; Anami Patel; James R Downing Journal: Blood Date: 2003-05-01 Impact factor: 22.113